Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO vs Eltrombopag in Chinese Adults with ITP
NCT03771378Phase 4Unknown
- Start
- Jan 2019
- Primary completion
- May 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of recombinant human thrombopoietin in primary immune thrombocytopenia (ITP). Status: unknown.
02
Drugs
recombinant human thrombopoietin
03
Conditions
primary immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT03771378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03771378.